# NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
> **ANDA208499** · Abbreviated New Drug Application (Generic) · Sponsor: PERRIGO R AND D · Approved 2019-05-10
## Drug
- **FDA Application Number:** ANDA208499
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
- **Generic name:** DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM
- **Active ingredients:** DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** PERRIGO R AND D
- **Manufacturer:** American Sales Company
- **First approval:** 2019-05-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208499)
---
*MORVS · CC0 1.0*